BackDoximity Overview
Doximity Inc - Ordinary Shares - Class A

Doximity Target Price

Analysts' average 12-month price target for Doximity is $24.

Get informed when a big investor buys or sells

+ Follow

Share Price

$21.89

Average Target Price

$24.4311.6% upside

14 analysts in the last 4 months

High: $35 | Low: $18

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-14Canaccord Genuity$3037% upsideOpen
2026-05-14Goldman Sachs$249.6% upsideOpen
2026-05-14Mizuho Securities$2618.8% upsideOpen
2026-05-14Morgan StanleyCraig Hettenbach$3559.9% upsideOpen
2026-05-14Leerink PartnersMichael Cherny$2514.2% upsideOpen
2026-05-14Wells Fargo$1817.8% downsideOpen
2026-05-14Jefferies$1913.2% downsideOpen
2026-05-14Robert W. BairdVikram Kesavabhotla$1817.8% downsideOpen
2026-05-14NeedhamScott Berg$2723.3% upsideOpen
2026-05-14Barclays$208.6% downsideOpen
2026-05-14Truist FinancialJailendra Singh$1913.2% downsideOpen
2026-05-14BMO CapitalSean Dodge$208.6% downsideOpen
2026-05-11Wells Fargo$3246.2% upsideOpen
2026-04-20Truist Financial$2932.5% upsideOpen
2026-03-17Loop Capital MarketsGene Mannheimer$3141.6% upsideOpen
2026-02-20Piper Sandler$4291.9% upsideOpen
2026-02-09Canaccord GenuityRichard Close$3455.3% upsideOpen
2026-02-06KeyBanc$3873.6% upsideOpen
2026-02-06Truist FinancialJailendra Singh$3769% upsideOpen
2026-02-06Goldman Sachs$3455.3% upsideOpen
2026-02-06Morgan Stanley$49123.8% upsideOpen
2026-02-06BMO Capital$2514.2% upsideOpen
2026-02-06BTIGDavid Larsen$50128.4% upsideOpen
2026-02-06NeedhamScott Berg$55151.3% upsideOpen
2026-02-06Piper SandlerJessica Tassan$4082.7% upsideOpen
2026-02-06Wells Fargo$45105.6% upsideOpen
2026-02-04Mizuho Securities$45105.6% upsideOpen
2026-01-20Wells FargoStan Berenshteyn$55151.3% upsideOpen
2026-01-09Goldman SachsDavid Roman$49123.8% upsideOpen
2026-01-08KeyBanc$60174.1% upsideOpen
2026-01-08RBC Capital$59169.5% upsideOpen
2026-01-08Truist FinancialJailendra Singh$62183.2% upsideOpen
2026-01-08Canaccord GenuityRichard Close$48119.3% upsideOpen
2026-01-08Canaccord Genuity$50128.4% upsideOpen
2025-12-15Morgan Stanley$65196.9% upsideOpen
2025-12-08BarclaysGlen Santangelo$63187.8% upsideOpen
2025-10-08Evercore ISI$81270% upsideOpen
2025-10-08KeyBancScott Schoenhaus$80265.5% upsideOpen
2025-10-01Goldman SachsDavid Roman$64192.4% upsideOpen
2025-09-18Canaccord GenuityRichard Close$67206.1% upsideOpen
2025-09-10Raymond James$75242.6% upsideOpen
2025-05-20Goldman SachsDavid Roman$50128.4% upsideOpen
2025-05-16Truist FinancialJailendra Singh$52137.6% upsideOpen
2025-05-16Raymond JamesBrian Peterson$65196.9% upsideOpen
2025-01-13Wells FargoStan Berenshteyn$4396.4% upsideOpen
2025-01-08KeyBancScott Schoenhaus$65196.9% upsideOpen
2024-11-14Truist FinancialJailendra Singh$49123.8% upsideOpen
2024-11-13Canaccord GenuityRichard Close$60174.1% upsideOpen
2024-11-08NeedhamScott Berg$65196.9% upsideOpen
2024-11-08Wells FargoStan Berenshteyn$4187.3% upsideOpen

Doximity (DOCS) FAQ

The latest target price for DOCS is $24. Investors often review this figure alongside Doximity's historical trend and sector peers before judging valuation or financial health.

Doximity trades near $21.89 while the consensus target sits at $24 (11.6% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting DOCS's target price ($24), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Doximity's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.